Background: Sarcomas of the esophagus are rare representing 0.1–1.5% of all esophageal tumors. We report a case of malignant peripheral nerve sheath tumor (MPNST) of the esophagus in a 60-year-old woman. Methods: The diagnosis was made preoperatively on endoscopic biopsy and confirmed after tumor resection by immunohistochemistry as well as electron microscopy. The patient underwent abdominal-thoracicen bloc esophagectomy with mediastinal lymphadenectomy and intrathoracic esophagogastrostomy. Results: Our therapeutic concept for the first case of a high-grade MPNST (malignant schwannoma) of the esophagus resulted in a recurrence-free interval of 4 years. Conclusion: The therapy of choice was abdominal-thoracic en bloc esophagectomy with tumor-free resection margins and esophageal reconstruction with the stomach. After R0-resection we found no indication for adjuvant radio- and/or chemotherapy.

Keywords:
Malignant peripheral nerve sheath tumor, Esophagus, Neural sarcomas, Diagnosis, Therapy
1.
Lauwers GY, Erlandson RA, Casper ES, Brennan MF, Woodruff JM: Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol 1993;17:887–897.
2.
Drews G, Keine S, Emmrich P, Lehmann J. Malignant tumor of the autonomic nervous system of the stomach (GAN-tumor): Case report of a new entity (in German). Zentralbl Chir 1992;117:564–58.
3.
Perch SJ, Soffen EM, Whittington R, Brooks JJ: Esophageal sarcoma. Surg Oncol 1991;48:194–198.
4.
Lukash WM, Hyams VJ, Nielson OF: Neurogenic neoplasms of the small bowel: Benign nonchromaffin paragangliom of the duodenum. Am J Dig Dis 1966;7:575.
5.
Herrera GA, DeMorales HP, Grizzle WE, Han SG: Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma). Light and electron microscopic study confirming the origin of the neoplasms. Dig Dis Sci 1984;29:275.
6.
Pinedo Moraleda F, Martinez Gonzales MA, Ballestin Carcavilla C, Vargas Castrillon J: Gastrointestinal autonomic nerve tumors: A case report with ultrastructural and immunohistochemical studies. Histopathology 1992;20:323–329.
7.
Ducatman BS, Scheithauer BW: Malignant peripheral nerve sheath tumor with divergent differentiation. Cancer 1984;54:1049–1057.
8.
Enzinger FM, Weiss SS: Soft Tissue Tumors, ed 3. St Louis, Mosby, 1995, pp 889–928.
9.
Woodruff JM: Tumors and tumorlike conditions of the peripheral nerve; in Ninfo V, Chung EB, Cavazzana AO (eds): Tumors and Tumor-Like Lesions of Soft Tissue. Contemporary Issues in Surgical Pathology. New York, Churchill Livingstone, 1991, vol 18, pp 205–228.
10.
Brooks JSJ, Freeman M, Enterline HAT: Malignant ‘Triton’ tumors. Natural history and immunohistochemistry of nine cases with literature review. Cancer 1985;55:2543–2585.
11.
Weiss SW: Histological Typing of Soft Tissue Tumours, ed 2. WHO International Histological Classification of Tumours. Springer, Berlin, 1994.
12.
Wittekind Ch, Wagner G: TNM-Klassifikation maligner Tumoren, 5 Aufl. Berlin, Springer, 1997.
13.
Van Unnik JAM, Coindre JM, Contesso C, Albus-Lutter CE, Schiodt T, Sylvester R, et al: Grading of soft tissue sarcomas: Experience of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 1993;29A:2089–2093.
14.
Hermanek P, Henson DE, Hutter RVP, Sobin LH (eds): UICC TNM Supplement 1993. A Commentary on Uniform Use. Berlin, Springer, 1993.
15.
Bloch MJ, Iozzo RV, Edmunds LH, Brooks JJ: Polypoid synovial sarcoma of the esophagus. Gastroenterology 1987;92:229–233.
16.
Choh JH, Khazei AH, Ihm HJ: Leiomyosarcoma of the esophagus: Report of a case and review of the literature. J Surg Oncol 1986;32:223–226.
© 2000 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.